Biotech
Scope
Date
~
-
Bio & Pharma
SK Bioscience sells stake in US vaccine developer Novavax
SK Bioscience Co., a drug-making arm of South Korea's No. 2 conglomerate SK Group, has sold a stake in Nasdaq-listed vaccine developer Novavax Inc. ...
Aug 16, 2024 (Gmt+09:00)
-
Korean stock market
Biotech stocks, foreigners’ top pick in Korea amid panic selling
Foreigners and institutional investors in the South Korean stock market picked biotechs as their favorite shares in hopes of a biopharma stock jump ...
Aug 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung to invest $52 mn in US biotech VC Flagship Pioneering
Samsung C&T Corp., its bio units Samsung Biologics Co. and Samsung Bioepis Co. and Samsung Venture Investment Corp. have committed a combined 72...
Jul 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung’s biotech duo on a roll with $1.1 bn CMO order
Samsung Group is on track to rise to the top of biosimilar companies in the world and become South Korea’s largest drug maker for contract man...
Jul 03, 2024 (Gmt+09:00)
-
Rights offerings
Dim outlook for Korean biotech firms’ rights offerings
South Korea’s bio and tech-heavy Kosdaq-listed Shaperon Inc. raised 12.7 billion won ($9.2 million) from its latest rights offering, selling o...
Jun 12, 2024 (Gmt+09:00)
-
Bio & Pharma
Korean biotech Bertis to join BIO 2024 for global reach
South Korean biotech Bertis Inc. will deliver presentations at the BIO International Convention, one of the world’s largest bio and healthcare...
May 29, 2024 (Gmt+09:00)
-
Bio & Pharma
Investors dump Korean biotech HLB stocks on FDA rejection
HLB Co. and its affiliate stocks tumbled on Friday on news that the South Korean biotech group’s highly anticipated new cancer treatment Rivoc...
May 17, 2024 (Gmt+09:00)
-
IPOs
Korean biotech Xcell Therapeutics eyes June IPO
South Korean biotech Xcell Therapeutics Inc., a developer of chemically defined media for in vitro cell culture, is aiming for a junior bourse Kosda...
May 16, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Life Science invests in US biotech firm Latus Bio
Samsung Life Science Fund, managed by Samsung Group’s venture investment arm, has invested in US biotechnology firm Latus Bio Inc. during the ...
May 03, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics signs ADC CDO deal with LegoChem Bio
Samsung Biologics Co. has agreed with South Korean biotech company LegoChem Biosciences Inc. to provide contract development organization (CDO) serv...
Feb 07, 2024 (Gmt+09:00)
-
Leadership & Management
Samsung’s Lee to spur M&As, new growth with ‘lost decade’ behind him
Cleared of wrongdoing charges that shackled his leadership for years, Samsung Group leader Jay Y. Lee now will actively seek mergers and acquisition...
Feb 05, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Orion to buy control of biotech startup LegoChem for $415 mn
South Korea’s snack and confectionery maker Orion Group has agreed to buy a controlling stake in LegoChem Biosciences Inc., a Korean biotech s...
Jan 15, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung eyes biotech investments via Flagship Pioneering
Samsung C&T Corp., Samsung Biologics Co. and Samsung Bioepis Co. will ramp up investments in US biotechnology startups in collaboration with Fla...
Jan 09, 2024 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio, Janssen sign $1.7 bn ADC licensing deal
LegoChem Biosciences Inc. has signed a blockbuster $1.7 billion deal to license out its proprietary antibody drug conjugate (ADC) candidate to Jasse...
Dec 26, 2023 (Gmt+09:00)
-
Upcoming IPOs
Peter Thiel-backed D&D Pharmatech gets preliminary nod for IPO
South Korean clinical-stage biotech D&D Pharmatech Inc. has won approval from the Korea Exchange’s preliminary review for listing on the j...
Dec 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics partners with Europe's largest VC
Samsung Biologics Co., the world's largest contract drug manufacturer, announced on Tuesday it has teamed up with global biotech venture capitalist ...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Proxy adviser ISS backs drug giant Celltrion's merger plan
South Korean drug giant Celltrion Group has received a positive recommendation from Institutional Shareholder Services (ISS), a global leading proxy...
Oct 06, 2023 (Gmt+09:00)
-
Bio & Pharma
NKMax's US subsidiary listed on Nasdaq
South Korean natural killer (NK) cell drugmaker NKMax Co. on Wednesday said its US subsidiary NKGen Biotech on Monday was listed on the Nasdaq Globa...
Oct 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Wellmarker Bio signs worth of $528 mn tech transfer deal
Wellmarker Bio, South Korea's oncology drug development company, announced on Monday that it has signed a technology transfer agreement with a Europ...
Sep 12, 2023 (Gmt+09:00)
-
Bio & Pharma
AriBio applies for Phase 3 clinical trials in China for oral dementia drug
South Korean clinical-stage biotech company AriBio Co. on Thursday said it applied for Phase 3 clinical trials on the anti-Alzheimer's candidate t...
Sep 08, 2023 (Gmt+09:00)
-
Bio & Pharma
GI Innovation seeks to license allergy therapy to Japan in 2023
South Korea’s GI Innovation Inc. aims to complete licensing of its allergic diseases treatment candidate to a Japanese drug company by year's ...
Jul 17, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea to bolster biotech R&D, benchmarking US' Boston
South Korea is poised to boost the biotech industry by accelerating research, education and business partnerships with the biopharmaceutical sector ...
Jun 01, 2023 (Gmt+09:00)
-
Bio & Pharma
BIO USA 2023 to draw S.Korean biotech leaders, startups
More than 500 South Korean companies from top business groups to AI-based biotech startups are slated to attend the Bio International Convention 202...
May 30, 2023 (Gmt+09:00)
-
Bio & Pharma
NKMax submits US subsidiary's securities report to SEC
The listing in the US of NKGen Biotech, the American subsidiary of South Korean developer of natural killer (NK) cell therapy NKMax Co., is coming i...
May 17, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung to nurture biotech as next growth engine after chips: Lee
Samsung Group leader Lee Jae-yong, currently in the US, has vowed to make biotechnology the conglomerate’s second core strategic business afte...
May 08, 2023 (Gmt+09:00)
-
Business & Politics
S.Korea, US to jointly invest $60 mn for student exchange programs
South Korea and the United States have agreed to jointly invest $60 million in the exchange of young professionals in the field of science and techn...
Apr 27, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Biorchestra signs tech transfer deal for drug delivery system
Biorchestra Co., a South Korean company specializing in RNA-based therapeutics, announced on Tuesday that it has entered into a joint research and o...
Mar 28, 2023 (Gmt+09:00)
-
IPOs
S.Korean biotech GI Innovation's IPO draws tepid market interest
South Korean biotech GI Innovation Inc. is slated to debut on the local public market at less than half of its pre-IPO investment value, facing luke...
Mar 20, 2023 (Gmt+09:00)
-
Energy
OCI to expand polysilicon line, buy back shares to boost corporate value
OCI Co., a leading South Korean chemical and green energy company, plans to significantly increase the size of its upcoming share buyback and cancel...
Mar 19, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korean biotech NKMax’s unit aims for US IPO
NKMax Co., a South Korean cancer drug maker, is in talks with local and foreign investors in a bid to list its California-based unit NKGen Biotech I...
Mar 14, 2023 (Gmt+09:00)
Latest News
- 1 Hyundai, Waymo forge multi-year, strategic partnership for self-driving vehicles
- 2 AI startup MarqVision raises $16.5 mn to close Series A
- 3 Taihan Cable wins $630 mn power grid project in Singapore
- 4 Korean startup scene is gloomy, say 2 out of 5 startup CEOs
- 5 MBK ups stakes for Korea Zinc to match buyback offer